CareTech (CTH): Half-year trading on track to deliver FY (BUY) | Synairgen* (SNG): AZD9412 (inhaled interferon beta) rights returned to Synairgen (CORP) | Servoca* (SVC): Resilient performance, confident on H2 (CORP) | Vipera* (VIP): Large contract underpins growth expectations (CORP) | Europa Oil & Gas* (EOG): FEL 2/13 – new prospectivity identified (CORP)
27 Apr 2017
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
27 Apr 2017 -
Author:
Guy Hewett | Mark Brewer | Cavendish Research -
Pages:
7
CareTech (CTH): Half-year trading on track to deliver FY (BUY) | Synairgen* (SNG): AZD9412 (inhaled interferon beta) rights returned to Synairgen (CORP) | Servoca* (SVC): Resilient performance, confident on H2 (CORP) | Vipera* (VIP): Large contract underpins growth expectations (CORP) | Europa Oil & Gas* (EOG): FEL 2/13 – new prospectivity identified (CORP)